Five drug groups compete for Danish risk sharing pilot scheme

Five drug groups want to have their products included in the new three-year pilot scheme for risk sharing in which companies cover additional reimbursement expenses if their products are prescribed for patients outside the defined target group. However, the pilot scheme will only cover two medicines.

Photo: Jacob Ehrbahn/ POLFOTO

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles